Heinz-Josef Schmitt1,*, Saidu Y2,3, Hrynkevych K1, Adam AM4, Ankunda C5, Barro C5, Chacon-Cruz E6,7, Cobanoglu Ö5, Costa B5, Gutiérrez-Melo N5, Kawalazira RC5, Khatiwada M5, Mahmood S1,8, Mukumbayi PM9, Müschenborn-Koglin S1, Naidu A5, Nikdel M5, Ribeiro-Moraes J5, Saha S5, Salloum M5, Sanicas MJ10, Stoma I11, Tan JVG12, and Sanicas M5
1Global Health Press, Singapore; 2CHAI Cameroon; 3Institute for Global Health, University of Siena, Italy; 4Mombasa County Head Research Coordinator; 5Vaccinologist; 6Department of Pediatric Infectious Diseases, Hospital General de Tijuana, Baja-California, Mexico; 7Autonomous University of Baja-California, Mexico; 8ShuHaRi Health, Dhaka, Bangladesh; 9Department of Pharmacology and Therapeutics, Clinical Pharmacology and Pharmacovigilance Unit, Faculty of Pharmaceutical Sciences, University of Kinshasa, Democratic Republic of Congo; 10Aix-Marseille Université, Centre de recherche en cancérologie de Marseille, Adhesion and Inflammation Lab, Marseille, France. 11Gomel State Medical University, Gomel, Belarus; 12Université Claude Bernard Lyon 1, 69100 Villeurbanne, France. *Corresponding author |
 |